Login / Signup

The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials : A Systematic Review and Meta-analysis.

Renata IskanderHannah MoyerDean A FergussonSean McGrathAndrea BenedettiJonathan Kimmelman
Published in: Annals of internal medicine (2024)
Canadian Institutes of Health Research.
Keyphrases
  • human health
  • phase ii
  • clinical trial
  • randomized controlled trial
  • risk assessment
  • drug induced
  • climate change